Apply Today!
National Cancer Institute New Funding Opportunities
Available for Small Businesses
The National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs encourage you to apply for the 2012 Omnibus Solicitation, an investigator-initiated grant funding opportunity that enables small businesses to apply for funding across a wide range of cancer-related topic areas. If your small business is looking for ways to advance its innovative cancer research to the next development stage, consider applying for the Omnibus Solicitation funding opportunities by April 5, 2012.
SBIR/STTR Reauthorization Act of 2011 UPDATE
As you may know, new legislation was recently passed to re-authorize the SBIR & STTR Programs. As the details are being determined, the Small Business Administration (SBA) have issued interim guidance which discusses the timeline for implementation of the provisions in the re-authorization and when public comment will be solicited on the proposed regulations and policy directives. Per this guidance, in FY2012, NIH will raise the set asides to 2.6% for SBIR and 0.35% for STTR. For all other provisions in the re-authorization however (including new eligibility rules), NIH will continue to work within the existing regulations and policy directives, until those regulations are amended and the policy directive is updated.
U.S. small businesses with the research capabilities and technological expertise described in the FY2012 Omnibus Solicitation are encouraged to submit investigator-initiated SBIR & STTR grant applications. For more general information about this opportunity, please click here..
To view the official 2012 SBIR & STTR Omnibus Solicitations, please visit:
PA-12-088, PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Receipt Dates: April 5, 2012; August 5, 2012; December 5, 2012
PA-12-089, PHS 2012-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Receipt Dates: April 5, 2012; August 5, 2012; December 5, 2012
Additional Funding Opportunities
The NCI SBIR & STTR Programs have additional grant funding opportunities available in a wide range of cancer-related topic areas. These grants share the deadline of April 5, 2012. Don’t miss your chance to apply! For a complete list of funding opportunities from the NCI SBIR & STTR Programs, please click here.
Benefits of NCI SBIR & STTR Funding
- SBIR & STTR awards provide recognition, visibility, and validation.
- SBIR & STTR funding can often be leveraged to help attract additional funding from third-party investors.
- Awards are not loans; no repayment is required.
- SBIR & STTR funding is non-dilutive capital (i.e., an award does not impact the company’s stock or shares in any way).
- Intellectual property rights to technologies developed under these programs are retained by the small business concern.
How to Apply
For resources and tips for applying, and for examples of SBIR grant applications, please click here..
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.
Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov
Trouble viewing this? You can view it also here.
National Cancer Institute SBIR & STTR Programs – 6116 Executive Boulevard, Suite 402 – Rockville, Maryland 20852
Follow The NCI on Twitter
